counterfeit
Please find all related articles below.
European Commissioner for Health and Consumer Policy, John Dalli, attended the 53rd Annual Meeting of the European Association of Full Line Wholesalers and outlined his health strategy for the Pharmaceutical Sector.
Commissioner Dalli started out his speech with the challenges that EU health systems are facing today. Among others, he mentioned increasing healthcare expenditures due to ageing, multiple morbidities and chronic diseases, higher patient expectations, and technological (...)
28/06/2012
The European Medicines Agency (EMA) launched last May 31st the new European database of suspected adverse drug reaction reports website.
The launch of this website is a positive first step in the implementation of the EudraVigilance access policy.
The information carried on the site relates to approximately 650 medicines and active substances authorised through the centralised procedure. Within a year the EMA aims to additionally publish suspected side-effect reports for common drug (...)
28/06/2012
The Council of Europe’s eTACT project project is a collaborative system to better, in support of the Falsified Medicines Directive, secure the legal supply-chain of medicinal products from manufacturers to consumers. It proposes a flexible structure that could provide patients with a role in the identification of falsified medicines by using new technology to check the authenticity of products. However, instead of ’empowering’ patients and enhancing trust, the effects (...)
21/06/2012
The International Narcotics Control Board published its Annual report 2011 in which it warns that an increasing number of illegal Internet pharmacies in the world target young audiences via social media - increasing risks of long-term addiction to medicines.
The International Narcotics Control Board has chosen to highlight this new trend as national and international regulations find it difficult to address the issue so far.
The Annual report 2011 points out that illicit drugs or (...)
01/03/2012
Belgian organisation "Action Platform for Health and Solidarity" organised a conference in the Belgian Senate to debate the impact of European trade policy on public health from a global perspective. This intervenes in a context in which the free trade agreements the European Union is negotiating with countries in the South can threaten the right to health.
The Belgian Parliamentary Committee on Foreign Affairs and Defence organised a conference on the impact of European trade policy on (...)
Also about:
environment
,
Trade and Health
,
Sustainable Development
,
Access to Medicines
,
Development and Health
,
poverty and health
,
Healthcare services
,
Services General Interest (SGI)
,
Patient safety
,
Health Inequalities
,
public health
,
mobility
,
professional mobility
,
intellectual property
,
food security
,
social determinants of health
,
education
,
global health
06/06/2010
The EU is about to conclude its Free Trade Agreement negociations with India. Current negotiations threaten the pivotal role India plays in supplying affordable generic versions of drugs throughout the developing world. EPHA provides more information on the issues at stake.
India`s role in access to affordable generic medicines
In recent years, India has become "the pharmacy of the developing world". Ninety-two percent of people living with HIV on treatment in low- and middle-income (...)
Also about:
Trade and Health
,
Access to Medicines
,
Communicable Diseases
,
Pharmaceuticals and Medicines
,
Development and Health
,
HIV/AIDS
,
poverty and health
,
Millenium Development Goals
,
vulnerable groups
,
pandemic preparedness
,
European Commission
03/05/2010
The French Presidency of the EU will run from 1 July 2008 until 31 December 2008.
On Health issues, the French Presidency has made some priorities:
1. Health Security: Anti-microbial resistance and mandate for the ECDC, Health Security Committee
2. Mental Health: Alzheimer
3. Tobacco: preparation of the EU towards the Conference of Parties, FCTC in November 2008.
4. Health Strategy
5. Directive on the application of Patient Rights on Cross border Health care: please find more (...)
14/07/2008
Contact Details
Executive Director
EAHP
Rue Abbé Cuypers, 3
B - 1040 Brussels
Belgium
Phone +32 2 741.68.22 and +32 2 741.68.29
Fax +32 2 734.79.10
Email Contact
info@eahp.eu
Website
http://www.eahp.eu
28/05/2008
Contact Details
Mr John Chave
Secretary General
Rue du Luxembourg, 19-21
B-1000 BRUSSELS
BELGIUM
Phone +32 2 238 08 18
Fax +32 2 238 08 19
Email Contacts
pharmacy@pgeu.eu
Website
http://www.pgeu.eu
Also about:
Access to Medicines
,
Pharmaceuticals and Medicines
,
Patient safety
,
Cross Border Healthcare Directive
,
eHealth
,
workforce
,
medical devices
,
professional mobility
,
pharmacovigilance
,
health system
,
Directive 36
,
EMA
15/10/2007
Contact details
Mr Sertac Ozmen
Member of the Central Committee
Willy Brandt Str. No: 9
TR-06690 CANKAYA - ANKARA
TURKEY
Phone +90 312 409 8100
Fax +90 312 409 8109
Email contact
teb@teb.org.tr
Website
www.teb.org.tr
11/04/2007